Summary
- Splice variants
- Transcript comparison
- Gene alleles
Sequence
- Secondary Structure
Comparative Genomics
Ontologies
- GO: Anatomical entity
Phenotypes
Genetic Variation
Gene expression
Pathway
Molecular interactions
Regulation
External references
Supporting evidence
ID History
- Gene history

Configure this page

Share this page

Bookmark this page

.

Gene: USP33 ENSDARG00000016163

.

Description

ubiquitin specific peptidase 33 [Source:ZFIN;Acc:ZDB-GENE-040426-2323]

Location

Chromosome 2: 8,717,155-8,777,496 forward strand.

GRCz11:CM002886.2

About this gene

This gene has 3 transcripts (splice variants), 211 orthologues, 41 paralogues and is associated with 6 phenotypes.

Transcripts

Show transcript tableHide transcript table

Transcript ID	Name	bp	Protein	Translation ID	Biotype	UniProt Match	Flags
ENSDART00000018114.9	USP33-202	3907	897aa	ENSDARP00000014516.7	Gene/transcipt that contains an open reading frame (ORF).Protein coding	A5PMR2	A single transcript chosen for a gene which is the most conserved, most highly expressed, has the longest coding sequence and is represented in other key resources, such as NCBI and UniProt. This is defined in detail on http://www.ensembl.org/info/genome/genebuild/canonical.htmlEnsembl Canonical, APPRIS P1: Transcript(s) expected to code for the main functional isoform based solely on the core modules in the APPRIS. APPRIS is a system to annotate alternatively spliced transcripts based on a range of computational methods to identify the most functionally important transcript(s) of a gene. APPRIS P1,
ENSDART00000133037.2	USP33-201	457	77aa	ENSDARP00000118654.1	Gene/transcipt that contains an open reading frame (ORF).Protein coding	-	3' truncation in transcript evidence prevents annotation of the end of the CDS.CDS 3' incomplete,
ENSDART00000137872.2	USP33-203	406	59aa	ENSDARP00000118131.1	Gene/transcipt that contains an open reading frame (ORF).Protein coding	-	3' truncation in transcript evidence prevents annotation of the end of the CDS.CDS 3' incomplete,

.

Summary

.

.